Literature DB >> 24321843

The Hachinski ischemic scale and cognition: the influence of ethnicity.

Leigh A Johnson1, Blair Cushing, Geoffrey Rohlfing, Melissa Edwards, Hedieh Davenloo, Darrin D'Agostino, James R Hall, Sid E O'Bryant.   

Abstract

OBJECTIVE: cardiovascular burden is considered a risk factor for the development of cognitive dysfunction and dementia. While this link is well established in the literature, implementing this work in primary care settings remains a challenge. The goal of this study is to examine the utility of the Hachinski Ischemic Scale (HIS) in identifying cognitive dysfunction and diagnosis of mild cognitive impairment (MCI) in an ethnically diverse sample.
METHODS: data were analysed on 517 participants (211 Mexican Americans and 306 non-Hispanic Whites) recruited from Project FRONTIER, a study of rural health. Neuropsychological measures were utilised to assess for cognitive functioning.
RESULTS: among non-Hispanic Whites, HIS scores were significantly related to poorer performance on tasks of global cognition [B (SE) = -0.13 (0.06), P = 0.02], immediate memory [B (SE) = -0.85 (0.26), P < 0.001], attention [B (SE) = -1.6 (0.36), P < 0.001] and executive functioning [B (SE) = 0.46 (0.12), P < 0.001], and significantly predicted diagnosis of MCI [odds ratio (OR) = 1.4; 95% confidence interval (CI) = 1.2-1.6]. For Mexican Americans, HIS scores were significantly related to immediate memory [B (SE) = -0.78 (0.28), P = 0.01], attention [B (SE) = -0.74 (0.36), P = 0.04] and executive functioning [B (SE) = 0.37 (0.14), P = 0.01]; however, HIS scores were not significantly related to diagnosis of MCI in Mexican Americans (OR = 1.2, 95% CI = 0.96-1.4, P = 0.116).
CONCLUSION: HIS scores were related to cognitive functioning; however, these results differed by ethnicity. It is possible that these findings indicate that vascular factors may increase risk for MCI among non-Hispanic Whites but not for Mexican Americans. These findings are consistent with past research that suggests risk factors for MCI may differ by ethnicity.

Entities:  

Keywords:  Cognition; Ethnic differences; Hachinski Ischemic Scale; Mexican American; Older people

Mesh:

Year:  2013        PMID: 24321843      PMCID: PMC4001171          DOI: 10.1093/ageing/aft189

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  28 in total

1.  Risk profiles of subtypes of mild cognitive impairment: the sydney memory and ageing study.

Authors:  Perminder S Sachdev; Darren M Lipnicki; John Crawford; Simone Reppermund; Nicole A Kochan; Julian N Trollor; Brian Draper; Melissa J Slavin; Kristan Kang; Ora Lux; Karen A Mather; Henry Brodaty
Journal:  J Am Geriatr Soc       Date:  2011-12-05       Impact factor: 5.562

Review 2.  The complex interplay of cardiovascular system and cognition: how to predict dementia in the elderly?

Authors:  Tuomas Kerola; Raimo Kettunen; Tuomo Nieminen
Journal:  Int J Cardiol       Date:  2010-11-20       Impact factor: 4.164

3.  Characterization of Mexican Americans with mild cognitive impairment and Alzheimer's disease.

Authors:  Sid E O'Bryant; Leigh Johnson; Valerie Balldin; Melissa Edwards; Robert Barber; Benjamin Williams; Michael Devous; Blair Cushings; Janice Knebl; James Hall
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

4.  Biomarkers of Alzheimer's disease among Mexican Americans.

Authors:  Sid E O'Bryant; Guanghua Xiao; Melissa Edwards; Michael Devous; Veer Bala Gupta; Ralph Martins; Fan Zhang; Robert Barber
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

5.  Cardiovascular disease risk factors among older black, Mexican-American, and white women and men: an analysis of NHANES III, 1988-1994. Third National Health and Nutrition Examination Survey.

Authors:  J Sundquist; M A Winkleby; S Pudaric
Journal:  J Am Geriatr Soc       Date:  2001-02       Impact factor: 5.562

6.  A blood-based algorithm for the detection of Alzheimer's disease.

Authors:  Sid E O'Bryant; Guanghua Xiao; Robert Barber; Joan Reisch; James Hall; C Munro Cullum; Rachelle Doody; Thomas Fairchild; Perrie Adams; Kirk Wilhelmsen; Ramon Diaz-Arrastia
Journal:  Dement Geriatr Cogn Disord       Date:  2011-08-24       Impact factor: 2.959

7.  Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study.

Authors:  Mindy J Katz; Richard B Lipton; Charles B Hall; Molly E Zimmerman; Amy E Sanders; Joe Verghese; Dennis W Dickson; Carol A Derby
Journal:  Alzheimer Dis Assoc Disord       Date:  2012 Oct-Dec       Impact factor: 2.703

8.  Cardiovascular risk factors and cognitive decline in middle-aged adults.

Authors:  D Knopman; L L Boland; T Mosley; G Howard; D Liao; M Szklo; P McGovern; A R Folsom
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

9.  Risk factors for mild cognitive impairment among Mexican Americans.

Authors:  Sid E O'Bryant; Leigh Johnson; Joan Reisch; Melissa Edwards; James Hall; Robert Barber; Michael D Devous; Donald Royall; Meharvan Singh
Journal:  Alzheimers Dement       Date:  2013-05-02       Impact factor: 21.566

10.  A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI.

Authors:  Sid E O'Bryant; Guanghua Xiao; Robert Barber; Ryan Huebinger; Kirk Wilhelmsen; Melissa Edwards; Neill Graff-Radford; Rachelle Doody; Ramon Diaz-Arrastia
Journal:  PLoS One       Date:  2011-12-07       Impact factor: 3.240

View more
  8 in total

1.  Vitamin C Supplementation, APOE4 Genotype and Cognitive Functioning in a Rural-Dwelling Cohort.

Authors:  K Chaudhari; N Sumien; L Johnson; D D'Agostino; M Edwards; R J Paxton; J R Hall; S O'Bryant
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

2.  Personalized Neurophysiological and Neuropsychological Assessment of Patients with Left and Right Hemispheric Damage in Acute Ischemic Stroke.

Authors:  Anastasia Tynterova; Svetlana Perepelitsa; Arкady Golubev
Journal:  Brain Sci       Date:  2022-04-26

3.  Population Difference in the Associations of KLOTH Promoter Methylation with Mild Cognitive Impairment in Xinjiang Uygur and Han Populations.

Authors:  Mei Luo; Xiaohui Zhou; Huihui Ji; Wenjuan Ma; Guili Liu; Dongjun Dai; Jingyun Li; Lan Chang; Lei Xu; Liting Jiang; Shiwei Duan; Qinwen Wang
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

4.  The Effect of Type 2 Diabetes Mellitus on Neuropsychological Symptoms in Chinese Early Alzheimer's Disease Population.

Authors:  Qianqian Shi; Faying Zhou; Jing Mei; Haimei Yang; Huiyun Li
Journal:  Neuropsychiatr Dis Treat       Date:  2020-03-26       Impact factor: 2.570

5.  Abnormal regional homogeneity in right caudate as a potential neuroimaging biomarker for mild cognitive impairment: A resting-state fMRI study and support vector machine analysis.

Authors:  Yujun Gao; Xinfu Zhao; JiChao Huang; Sanwang Wang; Xuan Chen; Mingzhe Li; Fengjiao Sun; Gaohua Wang; Yi Zhong
Journal:  Front Aging Neurosci       Date:  2022-09-01       Impact factor: 5.702

Review 6.  Neuropsychological assessment of mild cognitive impairment in Latinx adults: A scoping review.

Authors:  Emily M Briceño; Roshanak Mehdipanah; Xavier Fonz Gonzales; Kenneth M Langa; Deborah A Levine; Nelda M Garcia; Ruth Longoria; Bruno J Giordani; Steven G Heeringa; Lewis B Morgenstern
Journal:  Neuropsychology       Date:  2020-04-13       Impact factor: 3.295

7.  Antemortem Visit-To-Visit Blood Pressure Variability Predicts Cerebrovascular Lesion Burden in Autopsy-Confirmed Alzheimer's Disease.

Authors:  Isabel J Sible; Katherine J Bangen; Anna E Blanken; Jean K Ho; Daniel A Nation
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

8.  Visit-to-visit blood pressure variability and regional cerebral perfusion decline in older adults.

Authors:  Isabel J Sible; Belinda Yew; Shubir Dutt; Katherine J Bangen; Yanrong Li; Daniel A Nation
Journal:  Neurobiol Aging       Date:  2021-04-24       Impact factor: 4.673

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.